| Hang Seng Index | 23.720 HKD | -0.160 | -0.670% | 735.45M | 17.50B | 23.260 (+1.979%) HKD as at 2025/02/25 | | |
| Hang Seng China Enterprises | 88.500 HKD | -0.200 | -0.225% | 131.43M | 11.59B | 86.975 (+1.753%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 5.400 HKD | -0.060 | -1.099% | 592.40M | 3.21B | 5.580 (-3.229%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.935 HKD | -0.190 | -3.102% | 275.04M | 1.65B | 6.590 (-9.939%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.862 HKD | +0.054 | +2.987% | 694.53M | 1.28B | 1.831 (+1.671%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.572 HKD | +0.044 | +1.741% | 166.46M | 426.09M | 2.726 (-5.646%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.115 HKD | -0.105 | -2.011% | 57.80M | 297.15M | 5.000 (+2.306%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 11.530 HKD | -0.180 | -1.537% | 13.50M | 156.56M | 12.133 (-4.968%) HKD as at 2025/02/24 | | |
| Hang Seng TECH Index | 5.455 HKD | -0.100 | -1.800% | 19.89M | 108.98M | 5.659 (-3.596%) HKD as at 2025/02/25 | | |
| CSI 300 | 42.980 HKD | -0.320 | -0.739% | 1.76M | 75.91M | 43.473 (-1.134%) HKD as at 2025/02/25 | | |
| HSI ESG Enhanced Index (net total return index) | 48.360 HKD | -0.440 | -0.902% | 1.45M | 70.17M | 47.751 (+1.275%) HKD as at 2025/02/25 | | |
| Hang Seng China Enterprises | 10.880 HKD | -0.070 | -0.639% | 5.61M | 61.07M | 10.808 (+0.663%) HKD as at 2025/02/24 | | |
| FTSE China A50 | 12.820 HKD | -0.070 | -0.543% | 4.20M | 53.97M | 12.681 (+1.094%) HKD as at 2025/02/25 | | |
| London Gold Fixing Price | 2,209.000 HKD | +31.000 | +1.423% | 23.64K | 52.19M | N/A | | |
| FTSE China A50 | 13.740 HKD | -0.040 | -0.290% | 3.39M | 46.69M | 13.749 (-0.065%) HKD as at 2025/02/24 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 15.180 HKD | +0.420 | +2.846% | 2.00M | 30.28M | 13.980 (+8.587%) HKD as at 2025/02/24 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 5.740 HKD | +0.120 | +2.135% | 4.51M | 25.64M | 4.925 (+16.541%) HKD as at 2025/02/24 | | |
| Hang Seng TECH Index | 6.960 HKD | -0.110 | -1.556% | 3.16M | 22.05M | 7.219 (-3.590%) HKD as at 2025/02/25 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 11.120 HKD | +0.080 | +0.725% | 1.62M | 18.23M | 10.297 (+7.991%) HKD as at 2025/02/25 | | |
| Hang Seng Index | 22.160 CNY | -0.200 | -0.894% | 699.00K | 15.57M | 21.745 (+1.909%) CNY as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.298 HKD | -0.070 | -2.078% | 2.48M | 8.21M | 3.260 (+1.181%) HKD as at 2025/02/25 | | |
| Nikkei Stock Average Index | 78.460 HKD | -0.740 | -0.934% | 88.68K | 6.92M | 80.882 (-2.994%) HKD as at 2025/02/25 | | |
| Hang Seng Index | 23.780 HKD | -0.220 | -0.917% | 288.50K | 6.87M | 23.346 (+1.861%) HKD as at 2025/02/25 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng China Enterprises | 86.500 HKD | +1.320 | +1.550% | 76.49K | 6.54M | N/A | | |
| London Gold Fixing Price | 72.560 HKD | +1.300 | +1.824% | 89.70K | 6.50M | 69.203 (+4.851%) HKD as at 2025/02/25 | | |
| Hang Seng High Dividend Yield | 24.920 HKD | -0.120 | -0.479% | 254.10K | 6.32M | 24.714 (+0.833%) HKD as at 2025/02/24 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 10.470 HKD | -0.300 | -2.786% | 551.20K | 5.83M | 11.063 (-5.358%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 3.654 HKD | -0.034 | -0.922% | 1.54M | 5.64M | 3.748 (-2.518%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 0.874 HKD | +0.020 | +2.342% | 6.27M | 5.42M | 0.748 (+16.907%) HKD as at 2025/02/24 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 3.996 HKD | +0.036 | +0.909% | 1.35M | 5.39M | 4.098 (-2.499%) HKD as at 2025/02/25 | | |